"Goldman Sachs' head of technology equity capital markets shared a similar sentiment, with expectations that the IPO pipeline will double in 2025." That doesn't mean the 2025 IPO market will be a ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...

Zydus announces agreement with CVS Caremark to add ZituvioTM ZituvimetTM and ZituvimetTM XR (Sitagliptin / Sitagliptin and Metformin Hydrochloride) to its template formulary.

No other corporate actions details are available.